v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 289,366 $ 190,541 $ 770,582 $ 513,197
Cost of revenue 149,340 65,073 282,044 166,471
Gross profit 140,026 125,468 488,538 346,726
Operating expenses:        
Sales and marketing 334,911 119,666 536,082 337,255
Research and development 313,915 75,880 466,530 229,728
General and administrative 338,977 74,062 503,033 208,736
Total operating expenses 987,803 269,608 1,505,645 775,719
Loss from operations (847,777) (144,140) (1,017,107) (428,993)
Interest income 494 3,390 4,312 12,953
Interest expense (2,085) (173) (12,325) (395)
Change in fair value of warrants (9,201) 784 811 2,743
Other income (expense), net (3,293) 2,305 1,218 1,858
Loss before provision (benefit) for income taxes (861,862) (137,834) (1,023,091) (411,834)
Provision (benefit) for income taxes (8,543) 2,026 (5,043) 8,485
Net loss $ (853,319) $ (139,860) $ (1,018,048) $ (420,319)
Net loss per share attributable to common stockholders, basic $ (0.94) $ (0.24) $ (1.43) $ (0.73)
Net loss per share attributable to common stockholders, diluted $ (0.94) $ (0.24) $ (1.43) $ (0.73)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic 905,462,010 580,104,846 713,879,104 574,342,061
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted 905,462,010 580,104,846 716,027,459 574,342,061